Skip to main content

FDA recall, , Moderate risk

Beckman Coulter DxC 500I Clinical Analyzer Modules

Beckman Coulter DxC 500i Clinical Analyzer Modules have a software defect that can cause erroneous patient test results.

What happened

Beckman Coulter Inc. of Brea, California, recalled DxC 500 AU Clinical Analyzer Modules and DxC 500i Clinical Analyzer Modules using software version 1.5 or lower, including the DxC 500 AU Clinical Chemistry Analyzers.

A software defect in the Parameter Package import logic overwrites all predefined calculated test rules, including those previously modified by the user, upon import of a new Parameter Package version. This can cause user-customized calculated test rules to revert silently to their default expressions, potentially generating erroneous patient test results without an explicit error notification.

The recall began July 15, 2026, and was added to the FDA's Enforcement Report on August 17, 2026, with distribution worldwide, including nationwide in the US. Affected products include modules such as the AU w/out ISE and the DxC 500 AU Module w/ISE, DxC 500i.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

2 products

Match the list below, then check the codes the FDA notice also names.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. Beckman Coulter DxC 500i Clinical Analyzer Modules using software version 1.5 or lower

    UDI-DI
    • 14987666545089
    • 14987666545072
    • 15099590742331
  2. Beckman Coulter DxC 500 AU Clinical Analyzer Modules using software version 1.5 or lower

    UDI-DI
    • 14987666545058
    • 14987666545065

From the FDA notice

1) DxC 500 AU Module w/ISE, DxC 500i, Part Number C63522;

2) DxC 500 AU Module, DxC 500i, Part Number C63521;

3) Access 2 Module, DxC 500i, Part Number C13252; DxC 500 AU Clinical Chemistry Analyzers

Recall details

Company began the recall
Sold in

Worldwide distribution - US Nationwide.

Company
Beckman Coulter Inc.Brea, California
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
99436
Recall numbers
Z-2973-2026 to Z-2974-2026

All recalls from Beckman Coulter Inc.

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 2, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)